These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33684053)

  • 61. Paediatric research in the times of COVID-19.
    Fleming PF; Gale C; Molloy EJ; Faust SN; Costeloe K; Juszczak E; Roehr CC
    Pediatr Res; 2021 Aug; 90(2):267-271. PubMed ID: 33879846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modifications to Communities for Healthy Living trial design resulting from COVID-19.
    Davison KK; Haneuse S
    Contemp Clin Trials; 2020 Dec; 99():106205. PubMed ID: 33152514
    [No Abstract]   [Full Text] [Related]  

  • 63. An assessment of the informative value of data sharing statements in clinical trial registries.
    Ohmann C; Panagiotopoulou M; Canham S; Felder G; Verde PE
    BMC Med Res Methodol; 2024 Mar; 24(1):61. PubMed ID: 38461273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bringing platform trials closer to reality by enabling with digital research environment (DRE) connectivity.
    Barrett JS; Lasater K; Russell S; McCune S; Miller TM; Sibbald D
    Contemp Clin Trials; 2024 Jul; 142():107559. PubMed ID: 38714286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Challenges in operationalising clinical trials in India during the COVID-19 pandemic.
    Bassi A; Arfin S; Joshi R; Bathla N; Hammond NE; Rajbhandari D; Tirupakuzhi Vijayaraghavan BK; Venkatesh B; Jha V
    Lancet Glob Health; 2022 Mar; 10(3):e317-e319. PubMed ID: 34953516
    [No Abstract]   [Full Text] [Related]  

  • 66. ODT FLOW: Extracting, analyzing, and sharing multi-source multi-scale human mobility.
    Li Z; Huang X; Hu T; Ning H; Ye X; Huang B; Li X
    PLoS One; 2021; 16(8):e0255259. PubMed ID: 34351973
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ISO/TS 21564:2019- based Evaluation of a Semantic Map between Variables in the ISARIC Freestanding Follow Up Survey and ORCHESTRA Studies.
    Rinaldi E; Thun S; Stellmach C
    J Med Syst; 2023 Nov; 47(1):115. PubMed ID: 37962711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome.
    Collignon O; Burman CF; Posch M; Schiel A
    Clin Pharmacol Ther; 2021 Aug; 110(2):311-320. PubMed ID: 33506495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Coordination of COVID-19 platform trials in Europe.
    Demotes J; Simensen VC; Ueda K; Javaid S; Garcia P; Aydin B; Røttingen JA
    Trials; 2024 Apr; 25(1):278. PubMed ID: 38659031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sharing individual level data from observational studies and clinical trials: a perspective from NHLBI.
    Coady SA; Wagner E
    Trials; 2013 Jul; 14():201. PubMed ID: 23837497
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing.
    Galvin CJ; Fernandez-Luque L; Li YJ
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115070. PubMed ID: 34167045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The scientific chaos phase of the great pandemic: A longitudinal analysis and systematic review of the first surge of clinical research concerning COVID-19.
    Adami T; Ries M
    PLoS One; 2023; 18(11):e0289193. PubMed ID: 38033112
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Publishing protocols for trials of complex interventions before trial completion - potential pitfalls, solutions and the need for public debate.
    Basu AP; Pearse JE; Rapley T
    Trials; 2017 Jan; 18(1):5. PubMed ID: 28069042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delivering on NIH data sharing requirements: avoiding Open Data in Appearance Only.
    Watson H; Gallifant J; Lai Y; Radunsky AP; Villanueva C; Martinez N; Gichoya J; Huynh UK; Celi LA
    BMJ Health Care Inform; 2023 Jun; 30(1):. PubMed ID: 37344002
    [No Abstract]   [Full Text] [Related]  

  • 75. Responsiveness of open innovation to COVID-19 pandemic: The case of data for good.
    Scotti F; Pierri F; Bonaccorsi G; Flori A
    PLoS One; 2022; 17(4):e0267100. PubMed ID: 35472151
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COVID-19 pandemic is not the time of trial and error.
    Mohamed K; Rezaei N
    Am J Emerg Med; 2021 Aug; 46():774-775. PubMed ID: 32988694
    [No Abstract]   [Full Text] [Related]  

  • 77. Trials that infected people with common colds can inform today's COVID-19 challenge trials.
    Ewbank J
    Nature; 2024 May; 629(8013):757. PubMed ID: 38773287
    [No Abstract]   [Full Text] [Related]  

  • 78. Promotion of data sharing needs more than an emergency: An analysis of trends across clinical trials registered on the International Clinical Trials Registry Platform.
    Merson L; Ndwandwe D; Malinga T; Paparella G; Oneil K; Karam G; Terry RF
    Wellcome Open Res; 2022; 7():101. PubMed ID: 35419494
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations.
    Topaloglu U; Palchuk MB
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652541
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.
    Mohamed MF; Girish S; Humeniuk R; Nuthalapati S; Desai A; Datta-Mannan A; Gheyas F; Kanodia J; Cheeti S; Zhu T
    Clin Pharmacol Ther; 2024 Jul; 116(1):26-29. PubMed ID: 38536001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.